FEBS Letters · 2003 · 19 citations · 42 references
MedicineCardiologyPharmacologyCell SignalingInflammationInterventional CardiologyBalloon AngioplastyCarotid Artery StentingEndothelial ActivationEndothelial DysfunctionInflammatory SignalingEndothelial Function ModulationIntercellular Adhesion Molecule 1Prostaglandin-mediated InflammationVascular Cell Adhesion Molecule 1Vascular Endothelial DysfunctionVascular RemodelingVascular Remodeling Mechanisms
The aim of this study was to evaluate, using a rat model of balloon angioplasty, whether prostaglandin (PG) J(2) and 2-cyclopenten-1-one are able to reduce restenosis. We found that both PGJ(2) and 2-cyclopenten-1-one, administered by local application on carotid arteries, caused a dose-dependent inhibition of neointimal formation. Furthermore, both agents prevented vascular negative remodeling. The effect of these compounds on restenosis was correlated with an inhibition of nuclear factor-kappaB (NF-kappaB) activation as well as of intercellular adhesion molecule-1 (ICAM-1) protein expression in injured carotid arteries of control animals. Our results show that cyclopentenone PGs and their derivatives reduce restenosis and may have therapeutic relevance for the prevention of human restenosis.
42
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Mercedes Ricote, Andrew C. Li, Timothy M. Willson et al. · Nature · 1998 · 3.5K citations
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Chengyu Jiang, Adrian T. Ting, Brian Seed · Nature · 1998 · 2.9K citations
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Antonio Rossi, Pankaj Kapahi, Gioacchino Natoli et al. · Nature · 2000 · 1.3K citations